NCT06395688View on ClinicalTrials.gov

Drug-Drug Interaction Between THC and AEF0117

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Cannabis Abuse
Interventions
DRUG

3ß-(4-methoxybenzyloxy)pregn-5-en-20-one

AEF0117 soft capsules of 1mg

DRUG

Placebo

Placebo soft capsules (identical to active compound)

Sponsors

Lead Sponsor

Aelis Farma
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Aelis Farma

INDUSTRY

NCT06395688 - Drug-Drug Interaction Between THC and AEF0117 | Biotech Hunter | Biotech Hunter